{"id":"https://openalex.org/W2012127536","doi":"https://doi.org/10.1080/10428190600709572","title":"Distinct biological impact of dephosphorylation vs. downregulation of p210Bcr-Abl: Implications for imatinib mesylate response and resistance","display_name":"Distinct biological impact of dephosphorylation vs. downregulation of p210Bcr-Abl: Implications for imatinib mesylate response and resistance","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2012127536","doi":"https://doi.org/10.1080/10428190600709572","mag":"2012127536","pmid":"https://pubmed.ncbi.nlm.nih.gov/16966279"},"language":"en","primary_location":{"id":"doi:10.1080/10428190600709572","doi":"https://doi.org/10.1080/10428190600709572","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428190600709572","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["Division of Cancer Medicine, The University of Texas, M.D. Anderson Cancver Center, Houston, Texas 77230-1402, USA. rkurzroc@mdanderson.org","Departments of Experimental Therapeutics","Division of Cancer Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Medicine, The University of Texas, M.D. Anderson Cancver Center, Houston, Texas 77230-1402, USA. rkurzroc@mdanderson.org","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Departments of Experimental Therapeutics","institution_ids":[]},{"raw_affiliation_string":"Division of Cancer Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011529063","display_name":"Moshe Talpaz","orcid":"https://orcid.org/0000-0003-3361-3981","observed_orcids":["https://orcid.org/0000-0003-3361-3981"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moshe Talpaz","raw_affiliation_strings":["Departments of Experimental Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Experimental Therapeutics","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lan Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lan Li","raw_affiliation_strings":["Division of Cancer Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Medicine","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084290698","display_name":"Zeev E. Estrov","orcid":"https://orcid.org/0000-0002-1623-3613","observed_orcids":["https://orcid.org/0000-0002-1623-3613"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zeev Estrov","raw_affiliation_strings":["Leukeima, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukeima, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5053481267"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":0.2027,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.59286969,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"47","issue":"8","first_page":"1651","last_page":"1664"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p210-bcr-abl","display_name":"p210 BCR-ABL","score":0.8939999938011169},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.8870000243186951},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9100000262260437},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8270000219345093},{"id":"https://openalex.org/keywords/growth-factor-signaling","display_name":"growth factor signaling","score":0.6420000195503235}],"concepts":[{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.9377083778381348},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.6113078594207764},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.6090264916419983},{"id":"https://openalex.org/C171122931","wikidata":"https://www.wikidata.org/wiki/Q6324626","display_name":"K562 cells","level":3,"score":0.6039541959762573},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5973491668701172},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5822588205337524},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5269059538841248},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.4691644608974457},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4492168426513672},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35693880915641785},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3220806419849396},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.30449533462524414},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2631378173828125},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19398030638694763},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19005605578422546},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.17695742845535278},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.060605794191360474},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05536794662475586},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.05080711841583252},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001752","descriptor_name":"Blast Crisis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020014","descriptor_name":"K562 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/10428190600709572","doi":"https://doi.org/10.1080/10428190600709572","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428190600709572","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:16966279","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16966279","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W120419820","https://openalex.org/W1490418776","https://openalex.org/W1490860457","https://openalex.org/W1501358984","https://openalex.org/W1965295262","https://openalex.org/W1999614615","https://openalex.org/W2000799155","https://openalex.org/W2015616444","https://openalex.org/W2016086822","https://openalex.org/W2025206980","https://openalex.org/W2025564151","https://openalex.org/W2039925656","https://openalex.org/W2069093904","https://openalex.org/W2074740152","https://openalex.org/W2077047827","https://openalex.org/W2078336183","https://openalex.org/W2097822594","https://openalex.org/W2107015590","https://openalex.org/W2113703021","https://openalex.org/W2142969636","https://openalex.org/W2155221530","https://openalex.org/W2166490712","https://openalex.org/W2170875710","https://openalex.org/W2261096875","https://openalex.org/W2263837564","https://openalex.org/W2312804644","https://openalex.org/W2329648702","https://openalex.org/W2417884072"],"related_works":["https://openalex.org/W2979453157","https://openalex.org/W2075155467","https://openalex.org/W2081284522","https://openalex.org/W2979702269","https://openalex.org/W7220695781","https://openalex.org/W7160393842","https://openalex.org/W1504722631","https://openalex.org/W2135160560","https://openalex.org/W2113703021","https://openalex.org/W2069796323"],"abstract_inverted_index":{"Imatinib":[0,48],"mesylate":[1,22,49,67,129,186],"suppresses":[2],"phosphorylation":[3],"of":[4,13,72,83,120,135,147,153,164,166,172,175,178],"its":[5],"kinase":[6,16,90,180],"target,":[7],"Bcr-Abl.":[8],"We":[9,24,149],"hypothesized":[10],"that":[11,106,151,163],"loss":[12,174],"p210Bcr-Abl":[14,53,100,121,156,167],"(the":[15],"target)":[17],"may":[18,113,122,182],"lead":[19,183],"to":[20,184],"imatinib":[21,66,128,139,185],"resistance.":[23,187],"studied":[25],"K562":[26,58],"cells":[27,37,40,43,59],"[chronic":[28],"myelogenous":[29],"leukemia":[30],"(CML)":[31],"blast":[32,142],"crisis":[33,143],"line]":[34],"and":[35,87],"MO7E/MBA-1":[36],"(with":[38],"MBA-1":[39],"representing":[41],"MO7E":[42],"stably":[44],"transfected":[45],"with":[46,115,138],"BCR-ABL).":[47],"resistance":[50,130],"developed":[51],"when":[52,99],"expression":[54,85],"was":[55,101],"abolished.":[56],"Furthermore,":[57],"were":[60,78,97],"significantly":[61],"more":[62],"growth":[63,94],"suppressed":[64],"after":[65,70],"exposure":[68],"than":[69],"downregulation":[71],"Bcr-Abl":[73,84],"expression.":[74],"Signaling":[75],"pathways":[76],"which":[77,127],"functional":[79],"in":[80,169],"the":[81,93,176,179],"absence":[82],"(NF-kappaB":[86],"mitogen-activated":[88],"protein":[89],"activation":[91],"or":[92],"factor":[95],"pathway)":[96],"disrupted":[98],"present":[102],"but":[103,109],"dephosphorylated,":[104],"suggesting":[105],"an":[107],"intact,":[108],"enzymatically":[110],"inactive":[111],"Bcr-Abl,":[112],"interfere":[114],"critical":[116],"growth/signaling":[117],"pathways.":[118],"Downregulation":[119],"be":[123],"a":[124,154,158,170],"mechanism":[125],"by":[126],"emerges.":[131],"Samples":[132],"from":[133,162],"three":[134],"15":[136],"patients":[137],"mesylate-resistant":[140],"CML":[141],"had":[144],"undetectable":[145],"levels":[146],"p210Bcr-Abl.":[148],"conclude":[150],"retention":[152],"dephosphorylated":[155],"has":[157],"biologic":[159],"impact":[160],"distinct":[161],"downregulation/loss":[165],"and,":[168],"subset":[171],"patients,":[173],"target":[177],"inhibitor":[181]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}